Browse Category

NASDAQ:ACB 7 December 2025 - 12 December 2025

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) jumped about 15% in pre-market trading Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. The White House said no final decisions have been made. Investors responded to the potential for eased penalties and tax burdens. Aurora closed at $4.55 on Dec. 11 and was indicated near $5.30 early Friday.
12 December 2025
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis shares traded near US$4.60 on NASDAQ and C$6.39 on TSX as of early December, valuing the company at about US$260–280 million. The stock remains volatile, with a 34% drop from its February high but up 12–13% over the last 10 sessions. On December 2, Aurora’s MedReleaf Australia signed a distribution deal with Leafio, expanding access to over 4,000 pharmacies nationwide.
Go toTop